This inventor holds 1 USPTO granted patent. Top assignee: The University of Texas System. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Felipe Amaya-Manzanares: Innovator in Antibody Research
Introduction
Felipe Amaya-Manzanares is a notable inventor based in Houston, Texas. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies. His work is recognized for its potential impact on medical research and therapeutic applications.
Latest Patents
Felipe holds a patent titled "Anti-BST2 Antibodies Targeting BST2 Long Isoform." This patent represents a crucial advancement in the understanding and treatment of diseases related to the BST2 protein. His innovative approach could lead to new therapeutic strategies in combating various health conditions.
Career Highlights
Felipe is affiliated with The University of Texas System, where he engages in cutting-edge research. His role at the university allows him to collaborate with other experts in the field and contribute to the advancement of scientific knowledge. With a focus on antibody development, he continues to push the boundaries of what is possible in biotechnology.
Collaborations
Felipe collaborates with Long Vien, a fellow researcher, to enhance the scope and impact of their work. Their partnership exemplifies the importance of teamwork in scientific research, leading to innovative solutions and discoveries.
Conclusion
Felipe Amaya-Manzanares is a dedicated inventor whose work in antibody research holds promise for future medical advancements. His contributions to the field are invaluable, and his ongoing research will likely lead to significant breakthroughs in biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile